⌘K

Login Start Free

Home/Filings/4/0001214659-18-000757

4//SEC Filing

VandenBerg Amy 4

Accession 0001214659-18-000757

CIK 0001427570other

View on SEC.gov Company Profile

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 6:47 PM ET

Size

14.0 KB

Accession

0001214659-18-000757

Insider Transaction Report

Form 4

Period: 2018-01-29

OBALON THERAPEUTICS INCOBLN

VP of Reg. and Clin. Affairs

Transactions

Exercise/Conversion
Common Stock
2018-01-29$0.87/sh+4,022$3,499→ 4,022 total
Exercise/Conversion
Common Stock
2018-01-29$0.87/sh+1,087$946→ 5,109 total
Exercise/Conversion
Common Stock
2018-01-29$1.31/sh+1,541$2,019→ 6,650 total
Exercise/Conversion
Employee Stock Option (right to buy)
2018-01-29−4,022→ 0 total
Exercise: $0.87From: 2012-12-15Exp: 2018-12-15→ Common Stock (4,022 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2018-01-29−1,087→ 0 total
Exercise: $0.87From: 2013-12-24Exp: 2020-01-27→ Common Stock (1,087 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2018-01-29−1,541→ 0 total
Exercise: $1.31From: 2014-10-08Exp: 2021-01-26→ Common Stock (1,541 underlying)

Documents

1 file

4
marketforms-40861.xmlPrimary
PRIMARY DOCUMENT

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1

filerCIK 0001685638

Filing Metadata

Form type: 4
Filed: Jan 29, 7:00 PM ET
Accepted: Jan 30, 6:47 PM ET
Size: 14.0 KB

View on SEC.gov